These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9885796)

  • 1. Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.
    Gurguis GN; Antai-Otong D; Vo SP; Blakeley JE; Orsulak PJ; Petty F; Rush AJ
    Neuropsychopharmacology; 1999 Feb; 20(2):162-76. PubMed ID: 9885796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome.
    Gurguis GN; Vo SP; Griffith JM; Rush AJ
    Psychiatry Res; 1999 Dec; 89(2):73-95. PubMed ID: 10646827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.
    Gurguis GN; Blakeley JE; Antai-Otong D; Vo SP; Orsulak PJ; Petty F; Rush AJ
    J Psychiatr Res; 1999; 33(4):309-22. PubMed ID: 10404469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
    Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet alpha2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls.
    Gurguis GN; Andrews R; Antai-Otong D; Vo SP; Dikis EJ; Orsulak PJ; Rush AJ
    Psychopharmacology (Berl); 1999 Jan; 141(3):258-66. PubMed ID: 10027507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoreceptor coupling to GS protein in alcohol dependence, panic disorder, and patients with both conditions.
    Gurguis GN; Turkka J; George DT; Linnoila M
    Neuropsychopharmacology; 1997 Jan; 16(1):69-76. PubMed ID: 8981390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine for vestibular dysfunction in panic disorder: a prospective case series.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):196-201. PubMed ID: 21537560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil beta(2)-adrenoceptor function in major depression: G(s) coupling, effects of imipramine and relationship to treatment outcome.
    Gurguis GN; Vo SP; Griffith JM; Rush AJ
    Eur J Pharmacol; 1999 Dec; 386(2-3):135-44. PubMed ID: 10618463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia.
    Maddock RJ; Carter CS; Magliozzi JR; Gietzen DW
    Am J Psychiatry; 1993 Aug; 150(8):1219-25. PubMed ID: 8392297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The side effects burden of extended imipramine treatment of panic disorder.
    Mavissakalian MR; Perel JM
    J Clin Psychopharmacol; 2000 Oct; 20(5):547-55. PubMed ID: 11001240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
    Schneider LS; Munjack D; Severson JA; Palmer R
    Biol Psychiatry; 1987 Jan; 22(1):59-66. PubMed ID: 3790641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
    Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of the Panic and Agoraphobia Scale in a clinical trial.
    Bandelow B; Brunner E; Broocks A; Beinroth D; Hajak G; Pralle L; Rüther E
    Psychiatry Res; 1998 Jan; 77(1):43-9. PubMed ID: 10710174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
    Mavissakalian MR
    Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives.
    Cameron OG; Smith CB; Nesse RM; Hill EM; Hollingsworth PJ; Abelson JA; Hariharan M; Curtis GC
    Psychosom Med; 1996; 58(4):289-301. PubMed ID: 8827791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.